Workflow
Labcorp(LH)
icon
Search documents
Labcorp(LH) - 2020 Q4 - Earnings Call Transcript
2021-02-11 19:25
Laboratory Corporation of America Holdings (NYSE:LH) Q4 2020 Earnings Conference Call February 11, 2021 9:00 AM ET Company Participants Clarissa Willett - VP, IR Adam Schechter - Chairman and CEO Glenn Eisenberg - EVP and CFO Conference Call Participants Jack Meehan - Nephron Research Dan Leonard - Wells Fargo Lisa Gill - JPMorgan Erin Wright - Crédit Suisse Ralph Giacobbe - Citi Eric Coldwell - Baird Eugene Kim - Wolfe Research Pito Chickering - Deutsche Bank Adam Noble - UBS Ricky Goldwasser - Morgan Stan ...
Labcorp(LH) - 2020 Q3 - Quarterly Report
2020-10-29 13:54
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission file number 1-11353 LABORATORY CORPORATION OF AMERICA HOLDINGS (Exact name of registrant as specified in its charter) | Delaware | | 13-3 ...
Labcorp(LH) - 2020 Q3 - Earnings Call Transcript
2020-10-27 17:59
Laboratory Corporation of America Holdings (NYSE:LH) Q3 2020 Earnings Conference Call October 27, 2020 9:00 AM ET Company Participants Clarissa Willett - VP, IR Adam Schechter - President, CEO & Chairman Glenn Eisenberg - CFO & EVP Conference Call Participants Jack Meehan - Nephron Research Philip Chickering - Deutsche Bank Erin Wilson - Crédit Suisse Kevin Caliendo - UBS Investment Bank Lisa Gill - JPMorgan Chase & Co. Eric Coldwell - Robert W. Baird & Co. Donald Hooker - KeyBanc Capital Markets Brian Tanq ...
Labcorp(LH) - 2020 Q3 - Earnings Call Presentation
2020-10-27 13:52
THIRD QUARTER 2020 SUPPLEMENTAL FINANCIAL INFORMATION OCTOBER 27, 2020 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS 1 This presentation of Laboratory Corporation of America Holdings (the "Company") contains forward-looking statements, including, but not limited to, statements with respect to expectations for 2020 and the related assumptions, the impact of various factors on operating and financial results, including the projected impact of the COVID-19 pandemic on the Company's businesses, oper ...
Labcorp(LH) - 2020 Q2 - Quarterly Report
2020-07-31 20:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission file number 1-11353 LABORATORY CORPORATION OF AMERICA HOLDINGS (Exact name of registrant as specified in its charter) | Delaware | | 13-375737 ...
Labcorp(LH) - 2020 Q2 - Earnings Call Transcript
2020-07-28 17:20
Laboratory Corporation of America Holdings (NYSE:LH) Q2 2020 Results Conference Call July 28, 2020 9:00 AM ET Company Participants Clarissa Willett - VP, IR Adam Schechter - Chairman and CEO Glenn Eisenberg - EVP and CFO Conference Call Participants Eric Coldwell - Baird Jack Meehan - Nephron Research Stephen Baxter - Wolf Research Lisa Gill - JP Morgan Dan Leonard - Wells Fargo Donald Hooker - KeyBanc Justin Bowers - DB Ralph Giacobbe - Citi Ricky Goldwasser - Morgan Stanley Derik de Bruin - Bank of Americ ...
Labcorp(LH) - 2020 Q1 - Quarterly Report
2020-05-08 21:10
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 For the transition period from ______ to ______ Commission file number 1-11353 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 LABORATORY CORPORATION OF AMERICA HOLDINGS (Exact name of registrant as specified in its charter) | Delaware | | 13-37573 ...
Labcorp(LH) - 2020 Q1 - Earnings Call Transcript
2020-04-29 18:29
Laboratory Corporation of America Holdings (NYSE:LH) Q1 2020 Earnings Conference Call April 29, 2020 9:00 PM ET Company Representatives Adam Schechter - President, Chief Executive Officer Glenn Eisenberg - Executive Vice President, Chief Financial Officer Clarissa Willett - Vice President of Investor Relations Conference Call Participants Lisa Gill - JPMorgan Ralph Giacobbe - Citi Kevin Caliendo - UBS Dan Leonard - Wells Fargo Derik De Bruin - BOA Erin Wright - Crédit Suisse Ricky Goldwasser - Morgan Stanle ...
Labcorp(LH) - 2020 Q1 - Earnings Call Presentation
2020-04-29 13:56
FIRST QUARTER 2020 SUPPLEMENTAL FINANCIAL INFORMATION APRIL 29, 2020 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS 1 This presentation of Laboratory Corporation of America Holdings (the "Company") contains forward-looking statements, including, but not limited to, statements with respect to expectations for 2020 and the related assumptions, the impact of various factors on operating and financial results, including the projected impact of the COVID-19 pandemic on the Company's businesses, operat ...
Labcorp(LH) - 2019 Q4 - Annual Report
2020-02-28 19:42
Index UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K [☒] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2019 or [☐] Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ______ to ______ Commission file number - 1-11353 LABORATORY CORP OF AMERICA HOLDINGS (Exact name of registrant as specified in its charter) | Delaware | | 13-3757370 ...